--- title: "European Equities Traded in the US as American Depositary Receipts Higher Wednesday" description: "European equities traded in the US as American depositary receipts rose 1.28% on the S&P Europe Select ADR Index. Notable gainers included Equinor (up 3.4%) and ASML (up 3.3%). Decliners included Agom" type: "news" locale: "en" url: "https://longbridge.com/en/news/276251138.md" published_at: "2026-02-18T16:15:00.000Z" --- # European Equities Traded in the US as American Depositary Receipts Higher Wednesday > European equities traded in the US as American depositary receipts rose 1.28% on the S&P Europe Select ADR Index. Notable gainers included Equinor (up 3.4%) and ASML (up 3.3%). Decliners included Agomab Therapeutics (down 5.4%) and LuxExperience (down 5.2%). In the UK and Ireland, Compass Pathways gained 9.8%, while Trinity Biotech fell 3.3%. 11:15 AM EST, 02/18/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were rising on Wednesday morning, up 1.28% to 1,858.13 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by energy company Equinor ( EQNR ) and semiconductor firm ASML ( ASML ) , which rose 3.4% and 3.3% respectively. They were followed by clinical-stage biotech company Abivax ( ABVX ) and bank Banco Santander (SAN), which added 2.9% and 2.5%, respectively. The decliners from continental Europe were led by clinical-stage biopharmaceutical company Agomab Therapeutics ( AGMB ) and online shopping company LuxExperience (LUXE), which fell 5.4% and 5.2%, respectively. They were followed by healthcare company Fresenius (FMS), which was down 2.6%. From the UK and Ireland, the gainers were led by pharmaceutical company Compass Pathways ( CMPS ) and software development firm Endava ( DAVA ) , which gained 9.8% and 3.7% respectively. The decliners from the UK and Ireland were led by clinical diagnostic products provider Trinity Biotech ( TRIB ) and pharmaceutical company Silence Therapeutics ( SLN ) , which shed 3.3% and 3.2% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### Related Stocks - [CMPS.US - Compass Pathways](https://longbridge.com/en/quote/CMPS.US.md) - [ASML.US - ASML](https://longbridge.com/en/quote/ASML.US.md) - [AGMB.US - AgomAb Therapeutics NV](https://longbridge.com/en/quote/AGMB.US.md) - [TRIB.US - Trinity Biotech](https://longbridge.com/en/quote/TRIB.US.md) - [ASMG.US - Leverage Shares 2X Long ASML Daily ETF](https://longbridge.com/en/quote/ASMG.US.md) - [LUXE.US - LuxExperience BV](https://longbridge.com/en/quote/LUXE.US.md) - [EQNR.US - Equinor Asa](https://longbridge.com/en/quote/EQNR.US.md) - [SPEU.US - SPDR Portfolio Europe ETF](https://longbridge.com/en/quote/SPEU.US.md) - [FDD.US - First Trust STOXX EUROPE](https://longbridge.com/en/quote/FDD.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Compass Pathways 将出席于2026年3月2日至 4 日在马萨诸塞州波士顿举办的 TD Cowen 第 46 届年度医疗保健会议 \| CMPS 股票新闻 | Compass Pathways plc（纳斯达克代码：CMPS）将于 2026 年 3 月 2 日至 4 日在马萨诸塞州波士顿参加 TD Cowen 第 46 届年度医疗保健会议。管理层将于 2026 年 3 月 3 日上午 10:30（ | [Link](https://longbridge.com/en/news/276726781.md) | | ASML 发布 2025 年年度报告 \| ASML 股票新闻 | ASML Holding NV 发布了其 2025 年度报告，强调其在微芯片技术创新方面的承诺。报告详细介绍了 ASML 的商业模式、公司治理、可持续发展努力和财务表现，遵循美国通用会计准则（US GAAP）和欧洲国际财务报告准则（IFRS | [Link](https://longbridge.com/en/news/276840059.md) | | AlphaCore Capital LLC 持有 ASML Holding N.V.价值 353 万美元的股份 | AlphaCore Capital LLC 在第三季度将其在 ASML Holding N.V. 的持股增加了 60.1%，目前持有 3,642 股，价值 353 万美元。其他机构投资者也调整了他们的持仓。ASML 的股票开盘价为 1,52 | [Link](https://longbridge.com/en/news/277003934.md) | | 华盛顿信托顾问公司增持了 ASML Holding N.V. $ASML 的股份 | 华盛顿信托顾问公司在第三季度将其在阿斯麦（ASML Holding N.V.）的持股比例增加了 12,610.3%，目前持有 4,957 股，价值 480 万美元。其他机构投资者也增加了他们的持股。阿斯麦的股票开盘价为 1,469.59 美 | [Link](https://longbridge.com/en/news/276600951.md) | | EverSource Wealth Advisors LLC 购买了 ASML Holding N.V.的股票，股票代码为$ASML | EverSource Wealth Advisors LLC 在第三季度将其在 ASML Holding N.V. 的持股增加了 37.6%，目前持有 16,060 股，价值 1,550 万美元。其他机构投资者也调整了他们的持仓，加利福尼亚 | [Link](https://longbridge.com/en/news/276710610.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.